What skills, knowledge, tools, training and incentives do pharma sales reps need to make them really effective? Trends and Innovations in Sales Force Effectiveness presents critical insights based on the experience and opinions of eight senior sales and training excellence experts from the pharma industry in the US and Europe. Learn more.
The FDA announced the approval of Actavis' Viberzi (eluxadoline) and Valeant Pharmaceuticals' Xifaxan (rifaximin) for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Julie... Read More >>